|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shlomai A, de Jong YP and Rice CM: Virus
associated malignancies: The role of viral hepatitis in
hepatocellular carcinoma. Semin Cancer Biol. 26:78–88. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weinmann A, Koch S, Niederle IM,
Schulze-Bergkamen H, König J, Hoppe-Lotichius M, Hansen T, Pitton
MB, Düber C, Otto G, et al: Trends in epidemiology, treatment, and
survival of hepatocellular carcinoma patients between 1998 and
2009: An analysis of 1066 cases of a German HCC Registry. J Clin
Gastroenterol. 48:279–289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paranagua-Vezozzo DC, Ono SK,
Alvarado-Mora MV, Farias AQ, Cunha-Silva M, França JI, Alves VA,
Sherman M and Carrilho FJ: Epidemiology of HCC in Brazil: Incidence
and risk factors in a ten-year cohort. Annals of hepatology.
13:386–393. 2014.PubMed/NCBI
|
|
5
|
Ye QH, Qin LX, Forgues M, He P, Kim JW,
Peng AC, Simon R, Li Y, Robles AI, Chen Y, et al: Predicting
hepatitis B virus-positive metastatic hepatocellular carcinomas
using gene expression profiling and supervised machine learning.
Nat Med. 9:416–423. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tang H, Delgermaa L, Huang F, Oishi N, Liu
L, He F, Zhao L and Murakami S: The transcriptional transactivation
function of HBx protein is important for its augmentation role in
hepatitis B virus replication. J Virol. 79:5548–5556. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang H, Oishi N, Kaneko S and Murakami S:
Molecular functions and biological roles of hepatitis B virus ×
protein. Cancer Sci. 97:977–983. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tarocchi M, Polvani S, Marroncini G and
Galli A: Molecular mechanism of hepatitis B virus-induced
hepatocarcinogenesis. World J Gastroenterol. 20:11630–11640. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Buendia MA and Neuveut C: Hepatocellular
carcinoma. Cold Spring Harb Perspect Med. 5:a0214442015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bharadwaj M, Roy G, Dutta K, Misbah M,
Husain M and Hussain S: Tackling hepatitis B virus-associated
hepatocellular carcinoma-the future is now. Cancer Metastasis Rev.
32:229–268. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tian Y, Yang W, Song J, Wu Y and Ni B:
Hepatitis B virus X protein-induced aberrant epigenetic
modifications contributing to human hepatocellular carcinoma
pathogenesis. Mol Cell Biol. 33:2810–2816. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang SZ, Zhang AQ, Chen G, Zhang LD, Zhu
J, Li XW and Dong JH: Experimental study of epithelial-mesenchymal
transition induced by HBx protein in liver cancer cell. Zhonghua Yi
Xue Za Zhi. 90:818–821. 2010.PubMed/NCBI
|
|
13
|
Teng J, Wang X, Xu Z and Tang N:
HBx-dependent activation of Twist mediates STAT3 control of
epithelium-mesenchymal transition of liver cells. J Cell Biochem.
114:1097–1104. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lara-Pezzi E, Gómez-Gaviro MV, Gálvez BG,
Mira E, Iñiguez MA, Fresno M, Martínez-A C, Arroyo AG and
López-Cabrera M: The hepatitis B virus X protein promotes tumor
cell invasion by inducing membrane-type matrix metalloproteinase-1
and cyclooxygenase-2 expression. J Clin Invest. 110:1831–1838.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ou DP, Tao YM, Tang FQ and Yang LY: The
hepatitis B virus X protein promotes hepatocellular carcinoma
metastasis by upregulation of matrix metalloproteinases. Int J
Cancer. 120:1208–1214. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lara-Pezzi E, Majano PL, Yáñez-Mó M,
Carretero M, Moreno-Otero R, Sánchez-Madrid F and López-Cabrera M:
Effect of the hepatitis B virus HBx protein on integrin-mediated
adhesion to and migration on extracellular matrix. J Hepatol.
34:409–415. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lara-Pezzi E, Serrador JM, Montoya MC,
Zamora D, Yáñez-Mó M, Carretero M, Furthmayr H, Sánchez-Madrid F
and López-Cabrera M: The hepatitis B virus X protein (HBx) induces
a migratory phenotype in a CD44-dependent manner: Possible role of
HBx in invasion and metastasis. Hepatology. 33:1270–1281. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang JF, Guo YJ, Zhao CX, Yuan SX, Wang
Y, Tang GN, Zhou WP and Sun SH: Hepatitis B virus X protein
(HBx)-related long noncoding RNA (lncRNA) down-regulated expression
by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by
targeting the intermediate filament protein vimentin. Hepatology.
57:1882–1892. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng
X, Zhu Z, Jiao H, Lin J, Jiang K, et al: Hepatitis B virus X
protein represses miRNA-148a to enhance tumorigenesis. J Clin
Invest. 123:630–645. 2013.PubMed/NCBI
|
|
20
|
Zhang X, Liu S, Hu T, Liu S, He Y and Sun
S: Up-regulated microRNA-143 transcribed by nuclear factor kappa B
enhances hepatocarcinoma metastasis by repressing fibronectin
expression. Hepatology. 50:490–499. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zou LY, Zheng BY, Fang XF, Li D, Huang YH,
Chen ZX, Zhou LY and Wang XZ: HBx co-localizes with COXIII in
HL-7702 cells to upregulate mitochondrial function and ROS
generation. Oncol Rep. 33:2461–2467. 2015.PubMed/NCBI
|
|
22
|
Waris G, Huh KW and Siddiqui A:
Mitochondrially associated hepatitis B virus X protein
constitutively activates transcription factors STAT-3 and NF-kappa
B via oxidative stress. Mol Cell Biol. 21:7721–7730. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li W, Wu Z, Ma Q, Liu J, Xu Q, Han L, Duan
W, Lv Y, Wang F, Reindl KM and Wu E: Hyperglycemia regulates
TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic
cancer. Curr Cancer Drug Targets. 14:348–356. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu WS: The signaling mechanism of ROS in
tumor progression. Cancer Metastasis Rev. 25:695–705. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yoshihara E, Masaki S, Matsuo Y, Chen Z,
Tian H and Yodoi J: Thioredoxin/Txnip: Redoxisome, as a redox
switch for the pathogenesis of diseases. Front Immunol. 4:5142014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cheng GC, Schulze PC, Lee RT, Sylvan J,
Zetter BR and Huang H: Oxidative stress and thioredoxin-interacting
protein promote intravasation of melanoma cells. Exp Cell Res.
300:297–307. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goldberg SF, Miele ME, Hatta N, Takata M,
Paquette-Straub C, Freedman LP and Welch DR: Melanoma metastasis
suppression by chromosome 6: Evidence for a pathway regulated by
CRSP3 and TXNIP. Cancer Res. 63:432–440. 2003.PubMed/NCBI
|
|
28
|
Masaki S, Masutani H, Yoshihara E and
Yodoi J: Deficiency of thioredoxin binding protein-2 (TBP-2)
enhances TGF-b signaling and promotes epithelial to mesenchymal
transition. PloS One. 7:e399002012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei J, Shi Y, Hou Y, Ren Y, Du C, Zhang L,
Li Y and Duan H: Knockdown of thioredoxin-interacting protein
ameliorates high glucose-induced epithelial to mesenchymal
transition in renal tubular epithelial cells. Cell Signal.
25:2788–2796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu DB, Liu FW, Li J, Liu C, Liu L, Chen
EQ, Zhao LS, Tang H and Zhou TY: Intrahepatic IFN-alpha expression
in liver specimens from HBV-infected patients with different
outcomes. Eur Rev Med Pharmacol Sci. 17:2474–2480. 2013.PubMed/NCBI
|
|
31
|
Xia L, Huang W, Tian D, Zhang L, Qi X,
Chen Z, Shang X, Nie Y and Wu K: Forkhead box Q1 promotes
hepatocellular carcinoma metastasis by transactivating ZEB2 and
VersicanV1 expression. Hepatology. 59:958–973. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen W, Li M, Su GZ, Cao J, Sang W, Zhao
K, Wu QY, Zhu F and Xu KL: Establishment of mouse mesenchymal stem
cells overexpressing CXCR4 gene and evaluation of their functions.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 22:1391–1395. 2014.PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bai L, Xu X, Wang Q, Xu S, Ju W, Wang X,
Chen W, He W, Tang H and Lin Y: A superoxide-mediated
mitogen-activated protein kinase phosphatase-1 degradation and
c-Jun NH(2)-terminal kinase activation pathway for luteolin-induced
lung cancer cytotoxicity. Mol Pharmacol. 81:549–555. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dasari VR, Kaur K, Velpula KK, Gujrati M,
Fassett D, Klopfenstein JD, Dinh DH and Rao JS: Upregulation of
PTEN in glioma cells by cord blood mesenchymal stem cells inhibits
migration via downregulation of the PI3K/Akt pathway. PloS One.
5:e103502010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shi R, Zhao Z, Zhou H, Wei M, Ma WL, Zhou
JY and Tan WL: Reduced expression of PinX1 correlates to
progressive features in patients with prostate cancer. Cancer Cell
Int. 14:462014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: A study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ishak K, Baptista A, Bianchi L, Callea F,
De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN, et al:
Histological grading and staging of chronic hepatitis. J Hepatol.
22:696–699. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang X, Zhang JH, Chen XY, Hu QH, Wang
MX, Jin R, Zhang QY, Wang W, Wang R, Kang LL, et al: Reactive
oxygen species-induced TXNIP drives fructose-mediated hepatic
inflammation and lipid accumulation through NLRP3 inflammasome
activation. Antioxid Redox Signal. 22:848–870. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhou J, Yu Q and Chng WJ: TXNIP (VDUP-1,
TBP-2): A major redox regulator commonly suppressed in cancer by
epigenetic mechanisms. Int J Biochem Cell Biol. 43:1668–1673. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sheth SS, Bodnar JS, Ghazalpour A,
Thipphavong CK, Tsutsumi S, Tward AD, Demant P, Kodama T, Aburatani
H and Lusis AJ: Hepatocellular carcinoma in Txnip-deficient mice.
Oncogene. 25:3528–3536. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Le Jan S, Le Meur N, Cazes A, Philippe J,
Le Cunff M, Léger J, Corvol P and Germain S: Characterization of
the expression of the hypoxia-induced genes neuritin, TXNIP and
IGFBP3 in cancer. FEBS Lett. 580:3395–3400. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Semenza GL: The hypoxic tumor
microenvironment: A driving force for breast cancer progression.
Biochim Biophys Acta. 1863:382–391. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fraga A, Ribeiro R, Príncipe P, Lopes C
and Medeiros R: Hypoxia and prostate cancer aggressiveness: A tale
with many endings. Clin Genitourin Cancer. 13:295–301. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gunes A, Iscan E, Topel H, Avci ST,
Gumustekin M, Erdal E and Atabey N: Heparin treatment increases
thioredoxin interacting protein expression in hepatocellular
carcinoma cells. Int J Biochem Cell Biol. 65:169–181. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tao ZH, Wu WZ, Wang XL, Wan JL, Sun HC,
Wang L, Xia JL and Fan J: The establishment of a systematic
site-specific metastasis model of human hepatocellular carcinoma in
nude mouse. Zhonghua Gan Zang Bing Za Zhi. 19:110–113.
2011.PubMed/NCBI
|
|
47
|
Junn E, Han SH, Im JY, Yang Y, Cho EW, Um
HD, Kim DK, Lee KW, Han PL, Rhee SG and Choi I: Vitamin D3
up-regulated protein 1 mediates oxidative stress via suppressing
the thioredoxin function. J Immunol. 164:6287–6295. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ma J, Sun T, Park S, Shen G and Liu J: The
role of hepatitis B virus X protein is related to its differential
intracellular localization. Acta Biochim Biophys Sin (Shanghai).
43:583–588. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Henkler F, Hoare J, Waseem N, Goldin RD,
McGarvey MJ, Koshy R and King IA: Intracellular localization of the
hepatitis B virus HBx protein. J Gen Virol. 82:871–882. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Singh LP: Thioredoxin interacting protein
(TXNIP) and pathogenesis of diabetic retinopathy. J Clin Exp
Ophthalmol. 4:2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li X, Rong Y, Zhang M, Wang XL, LeMaire
SA, Coselli JS, Zhang Y and Shen YH: Up-regulation of thioredoxin
interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to
the impaired thioredoxin activity and increased ROS in
glucose-treated endothelial cells. Biochem Biophys Res Commun.
381:660–665. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Han JM, Kang JA, Han MH, Chung KH, Lee CR,
Song WK, Jun Y and Park SG: Peroxisome-localized hepatitis Bx
protein increases the invasion property of hepatocellular carcinoma
cells. Arch Virol. 159:2549–2557. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ryu SH, Jang MK, Kim WJ, Lee D and Chung
YH: Metastatic tumor antigen in hepatocellular carcinoma: Golden
roads toward personalized medicine. Cancer Metastasis Rev.
33:965–980. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Schek N, Bartenschlager R, Kuhn C and
Schaller H: Phosphorylation and rapid turnover of hepatitis B virus
X-protein expressed in HepG2 cells from a recombinant vaccinia
virus. Oncogene. 6:1735–1744. 1991.PubMed/NCBI
|
|
55
|
Kim JH, Kang S, Kim J and Ahn BY:
Hepatitis B virus core protein stimulates the proteasome-mediated
degradation of viral X protein. J Virol. 77:7166–7173. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Zhang Z, Sun E, Ou JH and Liang TJ:
Inhibition of cellular proteasome activities mediates
HBX-independent hepatitis B virus replication in vivo. J Virol.
84:9326–9331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL
and Liang TJ: Hepatitis B virus X protein is both a substrate and a
potential inhibitor of the proteasome complex. J Virol.
73:7231–7240. 1999.PubMed/NCBI
|
|
58
|
McClain SL, Clippinger AJ, Lizzano R and
Bouchard MJ: Hepatitis B virus replication is associated with an
HBx-dependent mitochondrion-regulated increase in cytosolic calcium
levels. J Virol. 81:12061–12065. 2007. View Article : Google Scholar : PubMed/NCBI
|
